Alpha thalassemia is a genetic disorder that affects the production of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. It is caused by mutations in the HBA1 and HBA2 genes, which provide instructions for making alpha-globin, a component of hemoglobin.
People with alpha thalassemia have decreased or absent production of alpha-globin, which leads to a shortage of functional hemoglobin. This can cause a variety of symptoms, depending on the severity of the condition.
There are four types of alpha thalassemia:
Alpha thalassemia can be diagnosed through a blood test that measures the levels of hemoglobin and red blood cells in the body. Genetic testing can also be used to identify mutations in the HBA1 and HBA2 genes.
Screening for alpha thalassemia is recommended for people of certain ethnicities, including those of Southeast Asian, Chinese, and Mediterranean descent. It is also recommended for couples who are planning to have children, as alpha thalassemia is an inherited disorder.
Alpha thalassemia is a genetic disorder that affects the production of hemoglobin. It can cause a variety of symptoms, ranging from mild to severe. Treatment depends on the severity of the condition. If you are at risk for alpha thalassemia, talk to your healthcare provider about screening and genetic testing.
To see full information about treatment please Sign up or Log in